Phenotypic analysis of the infused Epstein-Barr virus-specific cytotoxic T-lymphocyte lines
| Patient . | CD3+ . | CD8+ . | CD4+ . | γδ+ . | CD56+/CD3− . | CD3+/CD8+/CD56+ . |
|---|---|---|---|---|---|---|
| 1 | 82 | 80 | 4 | 3 | 10 | 6 |
| 2 | 90 | 84 | 7 | 33 | 8 | 10 |
| 3 | 98 | 84 | 22 | 2 | 2 | 13 |
| 4 | 92 | 22 | 70 | 8 | 5 | 5 |
| 5 | 99 | 96 | 4 | 1 | 1 | 39 |
| 6 | 98 | 8 | 90 | 0 | 2 | 4 |
| 7 | 68 | 40 | 28 | 20 | 28 | 21 |
| Patient . | CD3+ . | CD8+ . | CD4+ . | γδ+ . | CD56+/CD3− . | CD3+/CD8+/CD56+ . |
|---|---|---|---|---|---|---|
| 1 | 82 | 80 | 4 | 3 | 10 | 6 |
| 2 | 90 | 84 | 7 | 33 | 8 | 10 |
| 3 | 98 | 84 | 22 | 2 | 2 | 13 |
| 4 | 92 | 22 | 70 | 8 | 5 | 5 |
| 5 | 99 | 96 | 4 | 1 | 1 | 39 |
| 6 | 98 | 8 | 90 | 0 | 2 | 4 |
| 7 | 68 | 40 | 28 | 20 | 28 | 21 |
Data are reported as the percentage of positive cells.